Fierce Pharma

DECEMBER 19, 2024

In a move that follows an increasingly common trend in biopharma M&A, Novartis is shedding sites and staffers from the German cancer biotech it acquired earlier this year. | Novartis confirmed Thursday that its closing down MorphoSys sites in Munich and Boston in a move thats expected to result in around 330 layoffs. The company made the decision in November as it looks to integrate all portfolio activities into Novartis.

Biopharma 221

Biopharma 221

MedCity News

DECEMBER 19, 2024

AI should augment, not replace, human provider expertise. Explainability empowers healthcare professionals to work in tandem with AI, ensuring that patients receive the most accurate and informed care. The post Unlocking AI Explainability for Trustworthy Healthcare appeared first on MedCity News.

Healthcare 102

Healthcare Healthcare Patients Physicians 102

Fierce Pharma

DECEMBER 19, 2024

The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. | The FDA has doubled down on its decision to remove Eli Lillys tirzepatide from its list of products that are in shortage. The agencys move means that compounding pharmacies will have to halt production of their knockoff versions of diabetes drug Mounjaro and obesity treatment Zepbound.

FDA 192

FDA 192

pharmaphorum

DECEMBER 19, 2024

At its third attempt, Mesoblast has secured FDA approval for the first-ever mesenchymal stem cell (MSC) therapy, Ryoncil for acute GvHD in children.

FDA 96

FDA 96

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

DECEMBER 19, 2024

Following in the footsteps of several Big Pharma companies, another ALK inhibitor has made its entry into the U.S. | Following in the footsteps of Pfizer, Roche and Takeda, another ALK inhibitor has made its belated entry into the U.S. The FDA nod comes four years after its initial approval in China.

FDA 201

FDA Pharma 201

pharmaphorum

DECEMBER 19, 2024

Novo Holdings' $16.

82

82

pharmaphorum

DECEMBER 19, 2024

Neuralink rival Precision Neurosciences raises $102m for its brain-computer interface tech, plus financings for Redesign, DeepLife, TG0 and Tuva.

74

74

MedCity News

DECEMBER 19, 2024

Applications of SandboxAQs large quantitative models (LQMs) technology include running simulations that identify new biomarkers and optimize clinical development of drug candidates. The company spun out of Alphabet in 2022. The post AI Tech Firm SandboxAQ Adds $300M to Ramp Up Development of LQMs for Drug Discovery & More appeared first on MedCity News.

Biopharma 66

Biopharma 66

pharmaphorum

DECEMBER 19, 2024

Ottimo raises $140m for PD-1 and VEGF-targeting jankistomig, which the startup says is differentiated from bispecific antibodies in the class.

63

63

Pharmaceutical Technology

DECEMBER 19, 2024

Vertex said the Phase II trial met its primary endpoint, however there was only a minor difference to placebo.

59

59

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

DECEMBER 19, 2024

A trial of Vertex's suzetrigine in neuropathic back pain met its primary objective, but shares in the company fell as investors reacted to the data

58

58

Pharmaceutical Technology

DECEMBER 19, 2024

Mesoblast has gained US FDA approval for its mesenchymal stromal cell (MSC) therapy, Ryoncil (remestemcel-L), to treat SR-aGvHD.

FDA 59

FDA 59

pharmaphorum

DECEMBER 19, 2024

Novartis has confirmed it will shut down two MorphoSys sites in Germany and the US, with the loss of around 330 jobs, by the end of next year.

58

58

Pharmaceutical Technology

DECEMBER 19, 2024

BioAge Labs has entered a multi-year research partnership with Novartis to seek therapeutic drug targets for ageing-related conditions.

59

59

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

DECEMBER 19, 2024

Roche and Prothena's alpha-synuclein-targeting prasinezumab for Parkinson's fails again, leaving them sifting through the data for efficacy signals

57

57

Pharmaceutical Technology

DECEMBER 19, 2024

MSD has entered an exclusive global licence agreement with Hansoh Pharma for a preclinical oral small molecule GLP-1RA.

Pharma 59

Pharma 59

European Pharmaceutical Review

DECEMBER 19, 2024

With the life sciences and healthcare sectors increasing integration of artificial intelligence (AI) into their infrastructure, according to research by GlobalData, one-third of healthcare professionals considered data privacy is the primary obstacle, citing challenges such as robust safeguards, workflow integration, and stakeholder acceptance [being] essential to ensure AIs ethical implementation and long-term success. 1 These concerns are held alongside the promise of this technology and its p

Pharmaceutical 52

Pharmaceutical Ethics Medicine Pharma 52

Pharmaceutical Technology

DECEMBER 19, 2024

Novo Holdings has completed the previously announced acquisition of Catalent in an all-cash transaction valued at around $16.5bn.

59

59

Advertisement

Pharma Marketing Network

DECEMBER 19, 2024

Table of Contents Sr# Headings 1 Introduction: Understanding Pharma Brands 2 Top Pharma Brands and Their Strategies 3 Trends Transforming the Pharma Industry 4 Conclusion: Adapting to the Pharma Future Introduction: Understanding Pharma Brands Pharma brands are the cornerstones of the healthcare industry, serving as the bridge between groundbreaking innovation and patient care.

Leads 52

Leads Pharma Education Marketing 52

Pharmaceutical Technology

DECEMBER 19, 2024

In this issue: Recent US reproductive laws could limit womens participation in trials, how Pfizer outplayed Starboard, PreP therapies come to the fore, and more.

52

52

Pharma Marketing Network

DECEMBER 19, 2024

Table of Contents Sr# Headings 1 Introduction: Why Social Media Matters in Healthcare 2 The Unique Challenges of Healthcare Social Media Marketing 3 Effective Social Media Strategies for Pharma Success 4 Conclusion: Elevating Your Social Media Game Introduction: Why Social Media Matters in Healthcare In todays fast-paced digital landscape, healthcare social media marketing has become a game-changer for pharma brands.

Media 52

Media Healthcare Healthcare Marketing 52

PharmExec

DECEMBER 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

Pharmaceutical 52

Pharmaceutical 52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharma Marketing Network

DECEMBER 19, 2024

Table of Contents Sr# Headings 1 Introduction: Why Programmatic Advertising Matters 2 How Programmatic Advertising Works 3 Benefits for Pharma Marketing Strategies 4 Overcoming Challenges in Programmatic Advertising 5 Conclusion: Embracing the Future of Advertising Introduction: Why Programmatic Advertising Matters In the fast-paced world of digital marketing, programmatic advertising is changing the game for pharma marketers.

Marketing 52

Marketing Pharma Training Healthcare 52

Pharmaceutical Commerce

DECEMBER 19, 2024

A cohort study explores the connection between the two, along with the impact of educational attainment on this relationship.

Education 52

Education 52

Pharma Marketing Network

DECEMBER 19, 2024

Table of Contents Sr# Headings 1 Introduction: Why Audience Targeting Matters 2 Defining Target Audiences in Pharma Marketing 3 Strategies for Effective Audience Targeting 4 Challenges and Solutions in Audience Targeting 5 Conclusion: Enhancing Pharma Marketing Impact Introduction: Why Audience Targeting Matters In the competitive world of pharmaceuticals, audience targeting is more than a marketing toolits the backbone of every successful campaign.

Marketing 52

Marketing Pharma Patients Media 52

PharmaTech

DECEMBER 19, 2024

Scinai Bioservices Inc. has been established in Delaware as the company's new US-based subsidiary, which will serve biotech companies in early stage drug development.

52

52

Advertisement

Distribution

PharmaVoice

DECEMBER 19, 2024

A new antibody from Merck would join a market teeming with new entries, but plenty of regulatory and financial uncertainty.

Marketing 52

Marketing 52

pharmaphorum

DECEMBER 19, 2024

MSD has been rumoured to be considering a takeover of Viking Therapeutics in order to get a horse in the obesity therapy race, but chose instead to back a runner from China's Hansoh Pharma. The big pharma is paying Hansoh $112 million upfront to place its bet on oral GLP-1 receptor agonist HS-1035, with another $1.9 billion in milestones on offer if the drug makes it through to the market and hits sales objectives.

Pharma 52

Pharma Sales Marketing 52

Pharmaceutical Commerce

DECEMBER 19, 2024

The latest news for pharma industry insiders.

Pharma 52

Pharma 52

PharmExec

DECEMBER 19, 2024

OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales